Clinical trial
Named Patient Program With Rotigotine Transdermal System
NCT01095484 is registered in ClinicalTrials.gov with UCB Pharma as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Named Patient Program With Rotigotine Transdermal System
- Lead sponsor
- UCB Pharma
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 30, 2008
- Completion date
- December 31, 2012
- Enrollment
- 520 (actual)
- Sites
- 51
Conditions
As the registry lists them; a condition with its own page is linked.
conditions for which there is a documented medical necessity to receive treatment with rotigotine